KELLI IVY: Open Payments
NPI 1114673951 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,535 in 93 payments from 27 companies in 2025. Trend: 2023 $1,239 · 2024 $1,930 · 2025 $2,535
Food & beverage: $2,442Education: $93
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $279 |
| AstraZeneca Pharmaceuticals LP | 10 | $276 |
| ABBVIE INC. | 8 | $212 |
| GlaxoSmithKline, LLC. | 8 | $175 |
| PFIZER INC. | 4 | $143 |
| E.R. Squibb & Sons, L.L.C. | 7 | $136 |
| Myriad Genetic Laboratories, Inc. | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 5 | $120 |
| Incyte Corporation | 2 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $115 |
Products named: LIBTAYO, MYRISK, ENHERTU, ICLUSIG, OJJAARA, IBRANCE, EPKINLY, ZEPZELCA.
Industry payments across TX — which companies pay providers there.
